Latest News & Features
Big Pharma
A group of more than 100 medical, scientific, patient advocacy and women’s health organisations have opposed a recent proposal to amend section 101 of the US Patent Act. 6 June 2019
Europe
The EU’s General Court has upheld the European Union Intellectual Property Office’s finding that a trademark for dietary supplements was descriptive of the relevant services to an Italian speaking public. 6 June 2019
Americas
San Francisco-based biotech company Atomwise could be set to receive up to $1 million per target in milestone payments following a partnership agreement with Eli Lilly. 6 June 2019
Big Pharma
A German court has rejected a bid from French pharmaceutical company Sanofi to have a patent infringement case dismissed. 5 June 2019
article
European legislators and patent offices, and in-house pharma decision-makers will tackle current patent term extension challenges on June 25 & 26 at the Maritim Hotel München, Munich. 4 June 2019
Genetics
Danish research company Bioneer has secured a non-exclusive licence to CRISPR/Cas9 technology owned by French geneticist Emmanuelle Charpentier. 4 June 2019
Big Pharma
A Japanese court has dismissed a patent infringement lawsuit brought by Roche subsidiary Genentech against Sandoz, a division of Novartis. 4 June 2019
Big Pharma
The US Food and Drug Administration has sent a warning letter to a stem cell company for marketing a number of unapproved treatments for a variety of life-threatening conditions. 4 June 2019
Americas
American pharmaceutical company Eli Lilly has secured an exclusive licence for a non-opioid, non-addictive chronic pain treatment from Boston-based biotech company Centrexion Therapeutics. 3 June 2019
Americas
The University of California has settled a dispute over the use of a diagnostic tool in graduate research projects. 31 May 2019